Evidence map›Paper›PMID 42801435›Full record

ArticleFood and environmental virology2026

Long-Term Wastewater Genomic Surveillance Reveals SARS-CoV-2 Variant Dynamics in Italy from 2021 to 2025.

C Veneri, G Bonanno Ferraro, P Mancini, D Brandtner, M Iaconelli, D Congiu, A Franco, L Lucentini, C Del Giudice, M Rossi and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in Food and environmental virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

C VeneriNational Center for Water Safety (CeNSiA), Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
G Bonanno FerraroNational Center for Water Safety (CeNSiA), Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
P ManciniNational Center for Water Safety (CeNSiA), Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
D BrandtnerNational Center for Water Safety (CeNSiA), Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
M IaconelliNational Center for Water Safety (CeNSiA), Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
D CongiuNational Center for Water Safety (CeNSiA), Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
A FrancoNational Center for Water Safety (CeNSiA), Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
L LucentiniNational Center for Water Safety (CeNSiA), Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
C Del GiudiceNational Center for Water Safety (CeNSiA), Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
M RossiNational Center for Artificial Intelligence and Innovative Technologies for Health (IATIS), Istituto Superiore di Sanità, Rome, Italy.
G D'AvenioNational Center for Artificial Intelligence and Innovative Technologies for Health (IATIS), Istituto Superiore di Sanità, Rome, Italy.
P StefanelliDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
L AmbrosioDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
A MammoneDirectorate-General for Health Emergencies, Ministry of Health, Rome, Italy.
E SuffrediniDepartment of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, Rome, Italy.
SARI Network
G La RosaNational Center for Water Safety (CeNSiA), Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. giuseppina.larosa@iss.it.

Funding

European Commission 060701/2021/864481/SUB/ENV.C2
6 · The paper itself

Abstract

Long-term genomic surveillance of SARS-CoV-2 remains important as routine clinical testing and sequencing decline over time after the pandemic. We describe the temporal dynamics, methodological adaptation, and operational continuity of Italy's national wastewater variant surveillance from October 2021 to December 2025. Across 51 monthly surveys, 6,278 wastewater samples collected from 167 wastewater treatment plants in 18 Regions and 2 Autonomous Provinces were analysed by RT-qPCR and targeted spike sequencing using short- and long-amplicon Sanger and Oxford Nanopore Technology approaches. Overall, 1,186 samples yielded a successful long amplicon and an interpretable Sanger sequence, while 248 regional pools were characterized by ONT during the funded surveillance phase from October 2021 to March 2023. The data documented the replacement of Delta by Omicron, followed by the circulation of BA.1*, BA.2* and BA.4/BA.5* and the subsequent emergence of BQ*, XBB*, EG.5*, and JN.1* lineages, with periods of persistence and co-circulation. The analytical workflow was adapted as lineage-defining mutations changed. Since March 2023, surveillance continued voluntarily through December 2025 using only long-amplicon Sanger sequencing. A qualitative comparison with national periodic flash surveys to estimate the prevalence of SARS-CoV-2 variants on biological samples showed that the two systems broadly captured the same succession of major lineage transitions, although the variant prevalence estimates and wastewater lineage proportions were not directly comparable. These findings support the feasibility of a targeted and adaptable strategy for sustaining nationwide wastewater genomic surveillance across emergency and post-emergency phases and for complementing clinical surveillance when routine testing and sequencing are reduced.

Indexed as

COVID-19SARS-CoV-2WastewaterGenome, ViralGenomicsHumansItalyWastewater-Based Epidemiological MonitoringWastewaterAmplicon sequencingGenomic surveillanceSARS-CoV-2VariantsWastewater-based epidemiology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.